{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:32:34Z","timestamp":1776760354859,"version":"3.51.2"},"reference-count":37,"publisher":"Sociedade Brasileira de Cardiologia","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,7]]},"DOI":"10.36660\/abc.20201165","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T12:55:08Z","timestamp":1649681708000},"page":"768-777","source":"Crossref","is-referenced-by-count":6,"title":["Ceramidas Plasm\u00e1ticas na Estratifica\u00e7\u00e3o de Risco das Doen\u00e7as Cardiovasculares"],"prefix":"10.36660","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4526-4766","authenticated-orcid":false,"given":"D\u00e9bora L. M.","family":"Junqueira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7184-1251","authenticated-orcid":false,"given":"Alline","family":"Stach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Caixeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-4447","authenticated-orcid":false,"given":"Juliana","family":"Sallum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Yasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeane","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Rizatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Rochitte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ching-Jianhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Kovalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5464-1792","authenticated-orcid":false,"given":"Jos\u00e9 E.","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo P. de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"6","key":"key20220411085502_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5935\/abc.2013S012","article-title":"I Brazilian Guidelines for cardiovascular prevention","volume":"101","author":"Simao","year":"2013","unstructured":". Simao AF, Precoma DB, Andrade JP, Correa FH, Saraiva JFK, Oliveira GMM, et al. [I Brazilian Guidelines for cardiovascular prevention]. Arq Bras Cardiol. Dec 2013;101(6 Suppl 2):1-63. doi: 10.5935\/abc.2013S012.","journal-title":"Arq Bras Cardiol"},{"issue":"23","key":"key20220411085502_B2","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"Hamm","year":"2011","unstructured":". Hamm CW, Bassand JP, Agewall S, Bt J, Boersma E, Caso P, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. Dec 2011;32(23):2999-3054. doi: 10.1093\/eurheartj\/ehr236.","journal-title":"Eur Heart J. Dec"},{"issue":"19","key":"key20220411085502_B3","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2014.15095","article-title":"Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction","volume":"312","author":"Park","year":"2014","unstructured":". Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. Nov 19 2014;312(19):2019-27. doi: 10.1001\/jama.2014.15095.","journal-title":"JAMA"},{"issue":"21","key":"key20220411085502_B4","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevencion con Dieta Mediterranea)","volume":"135","author":"Wang","year":"2017","unstructured":". Wang DD, Toledo E, Hruby A, Rosnet BA, Willett WC, Sun Q, et al. Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevencion con Dieta Mediterranea). Circulation. May 23 2017;135(21):2028-40. doi: 10.1161\/CIRCULATIONAHA.116.024261.","journal-title":"Circulation"},{"issue":"25","key":"key20220411085502_B5","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","unstructured":". Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D, et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J. Jul 1 2016;37(25):1967-76. doi: 10.1093\/eurheartj\/ehw148.","journal-title":"Eur Heart J"},{"issue":"5","key":"key20220411085502_B6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/jnc.14225","article-title":"Activation of the NLRP3 inflammasome in microglia: the role of ceramide","volume":"143","author":"Scheiblich","year":"2017","unstructured":". Scheiblich H, Schlutter A, Golenbock DT, Latz E, Martinez-Martinez P, Heneka MT. Activation of the NLRP3 inflammasome in microglia: the role of ceramide. J Neurochem. Dec 2017;143(5):534-50. doi: 10.1161\/ATVBAHA.116.307497.","journal-title":"J Neurochem"},{"issue":"12","key":"key20220411085502_B7","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort","volume":"36","author":"Havulinna","year":"2016","unstructured":". Havulinna AS, Sysi-Aho M, Hilvo M, Kauanen D, Hurme R, Ekroos K, et al. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort. Arterioscler Thromb Vasc Biol. Dec 2016;36(12):2424-30. doi: 10.1161\/ATVBAHA.116.307497.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"key20220411085502_B8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis","volume":"22","author":"Xia","year":"2015","unstructured":". Xia JY, Holland WL, Kusminski CM, Sun K, Sharma AX, Pearson MJ, et al. Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis. Cell Metab. Aug 4 2015;22(2):266-78. doi: 10.1016\/j.cmet.2015.06.007","journal-title":"Cell Metab"},{"issue":"6","key":"key20220411085502_B9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.116.305675","article-title":"Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation","volume":"36","author":"Edsfeldt","year":"2016","unstructured":". Edsfeldt A, Duner P, Stahlman M, Mollet IG, Ascinto G, Grulman H, et al. Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation. Arterioscler Thromb Vasc Biol. Jun 2016;36(6):1132-40. doi: 10.1161\/ATVBAHA.116.305675.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"key20220411085502_B10","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1161\/01.ATV.15.10.1607","article-title":"Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis","volume":"15","author":"Mukhin","year":"1995","unstructured":". Mukhin DN, Chao FF, Kruth HS. Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler Thromb Vasc Biol. Oct 1995;15(10):1607-15. DOI: 10.1161\/01.atv.15.10.1607","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"key20220411085502_B11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.ATV.18.10.1523","article-title":"Sphingolipids in atherosclerosis and vascular biology","volume":"18","author":"Chatterjee","year":"1998","unstructured":". Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol. Oct 1998;18(10):1523-33. DOI: 10.1161\/01.atv.15.10.1607","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"key20220411085502_B12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/glycob\/7.1.57","article-title":"Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues","volume":"7","author":"Chatterjee","year":"1997","unstructured":". Chatterjee SB, Dey S, Shi WY, Thomas K, Hutchins GM. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. Glycobiology. Feb 1997;7(1):57-65. DOI: 10.1093\/glycob\/7.1.57","journal-title":"Glycobiology"},{"issue":"2","key":"key20220411085502_B13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacbts.2017.12.005","article-title":"Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction","volume":"3","author":"de Carvalho","year":"2018","unstructured":". de Carvalho LP, Tan SH, Ow GS, Tang Z, Ching J, Kovalik JP, et al. Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction. JACC Basic Transl Sci. Apr 2018;3(2):163-75. doi: 10.1016\/j.jacbts.2017.12.005.","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"key20220411085502_B14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.atherosclerosis.2015.10.022","article-title":"Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study","volume":"243","author":"Cheng","year":"2015","unstructured":". Cheng JM, Suoniemi M, Kardys I, Vihenvara T, de Boer SP, Akkerhuis KM, et al. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study. Atherosclerosis. Dec 2015;243(2):560-6. doi: 10.1016\/j.atherosclerosis.2015.10.022.","journal-title":"Atherosclerosis"},{"issue":"4","key":"key20220411085502_B15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.beem.2006.09.007","article-title":"Pathophysiology of insulin resistance","volume":"20","author":"Sesti","year":"2006","unstructured":". Sesti G. Pathophysiology of insulin resistance. Best Pract Res Clin Endocrinol Metab. Dec 2006;20(4):665-79. DOI: 10.1016\/j.beem.2006.09.007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"key20220411085502_B16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2337\/diabetes.51.5.1437","article-title":"Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated","volume":"51","author":"Lupi","year":"2002","unstructured":". Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes. May 2002;51(5):1437-42. doi: 10.2337\/diabetes.51.5.1437.","journal-title":"Diabetes"},{"issue":"7","key":"key20220411085502_B17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2337\/diabetes.48.7.1372","article-title":"Activation of the sphingomyelinase\/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death","volume":"48","author":"Major","year":"1999","unstructured":". Major CD, Gao ZY, Wolf BA. Activation of the sphingomyelinase\/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death. Diabetes. Jul 1999;48(7):1372-1380. doi: 10.2337\/diabetes.48.7.1372.","journal-title":"Diabetes"},{"issue":"1","key":"key20220411085502_B18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/dme.13943","article-title":"Ceramides and diabetes mellitus: an update on the potential molecular relationships","volume":"37","author":"Yaribeygi","year":"2020","unstructured":". Yaribeygi H, Bo S, Ruscica M, Sahebkar A. Ceramides and diabetes mellitus: an update on the potential molecular relationships. Diabet Med. Jan 2020;37(1):11-19. doi: 10.1111\/dme.13943","journal-title":"Diabet Med"},{"issue":"7","key":"key20220411085502_B19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/ATVBAHA.112.251538","article-title":"Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice","volume":"32","author":"Li","year":"2012","unstructured":". Li Z, Fan Y, Liu J, Li Y, Huan C, Bui HH, et al. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice. Arterioscler Thromb Vasc Biol. Jul 2012;32(7):1577-84. doi: 10.1161\/ATVBAHA.112.251538","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20220411085502_B20","author":"Mayo Clinic","unstructured":". Mayo Clinic. Ceramides: a class of lipids with links to heart disease. [Cited in 2020 June 12] Available at:https:\/\/www.mayoclinic.org","journal-title":"Ceramides: a class of lipids with links to heart disease"},{"key":"key20220411085502_B21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.29381\/0103-8559\/20172702163-70","article-title":"Uso racional dos exames diagn\u00f3sticos em cardiologia","volume":"27","author":"Pinto","year":"2017","unstructured":". Pinto IMF. Uso racional dos exames diagn\u00f3sticos em cardiologia. Rev So Cardiol Est S\u00e3o Paulo. 2017 2017;27:163-70.","journal-title":"Rev So Cardiol Est S\u00e3o Paulo"},{"issue":"6","key":"key20220411085502_B22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0066-782X2012000600012","article-title":"Coronary artery calcium score and coronary computed tomographic angiography for cardiovascular risk stratification","volume":"98","author":"Azevedo","year":"2012","unstructured":". Azevedo CF, Rochitte CE, Lima JA. Coronary artery calcium score and coronary computed tomographic angiography for cardiovascular risk stratification. Arq Bras Cardiol. Jun 2012;98(6):559-68. doi: 10.1590\/s0066-782x2012000600012.","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"key20220411085502_B23","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1161\/STROKEAHA.114.005669","article-title":"Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic Study of Atherosclerosis","volume":"45","author":"Tattersall","year":"2014","unstructured":". Tattersall MC, Gassett A, Korcarz CE, Gepner AD, Kaufman JD, Liu KJ, et al. Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic Study of Atherosclerosis. Stroke. Nov 2014;45(11):3257-62. doi: 10.1161\/STROKEAHA.114.005669","journal-title":"Stroke"},{"issue":"9438","key":"key20220411085502_B24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","unstructured":". Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lonas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. Sep 11-17 2004;364(9438):937-52. doi: 10.1161\/STROKEAHA.114.005669","journal-title":"Lancet"},{"issue":"4","key":"key20220411085502_B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5935\/abc.2013S010","article-title":"V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis","volume":"101","author":"Xavier","year":"2013","unstructured":". Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al. [V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis]. Arq Bras Cardiol. Oct 2013;101(4 Suppl 1):1-20. doi: 10.5935\/abc.2013S010.","journal-title":"Arq Bras Cardiol"},{"issue":"9","key":"key20220411085502_B26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1194\/jlr.C088377","article-title":"The ceramide ratio: a predictor of cardiometabolic risk","volume":"59","author":"Tippetts","year":"2018","unstructured":". Tippetts TS, Holland WL, Summers SA. The ceramide ratio: a predictor of cardiometabolic risk. J Lipid Res. Sep 2018;59(9):1549-50. doi: 10.1194\/jlr.C088377.","journal-title":"J Lipid Res"},{"issue":"3","key":"key20220411085502_B27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cjca.2014.12.007","article-title":"Ceramide is upregulated and associated with mortality in patients with chronic heart failure","volume":"31","author":"Yu","year":"2015","unstructured":". Yu J, Pan W, Shi R, Yang T, Li Y, Yu Y, et al. Ceramide is upregulated and associated with mortality in patients with chronic heart failure. Can J Cardiol. Mar 2015;31(3):357-63. doi: 10.1016\/j.cjca.2014.12.007","journal-title":"Can J Cardiol"},{"issue":"10","key":"key20220411085502_B28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007931","article-title":"Ceramide Remodeling and Risk of Cardiovascular Events and Mortality","volume":"7","author":"Peterson","year":"2018","unstructured":". Peterson LR, Xanthakis V, Duncan MS, Gross S, Friedrich N, Volzke H, et al. Ceramide Remodeling and Risk of Cardiovascular Events and Mortality. J Am Heart Assoc. May 3 2018;7(10):e007931. doi: 10.1161\/JAHA.117.007931.","journal-title":"J Am Heart Assoc"},{"key":"key20220411085502_B29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2019.01.048","article-title":"Relation between baseline LDL-cholesterol and cardiovascular outcomes in high cardiovascular risk hypertensive patients: A post-hoc SPRINT data analysis","volume":"286","author":"Nguyen","year":"2019","unstructured":". Nguyen LS, Procopi N, Salem JE, Squara P, Funck-Brentano C. Relation between baseline LDL-cholesterol and cardiovascular outcomes in high cardiovascular risk hypertensive patients: A post-hoc SPRINT data analysis. Int J Cardiol. Jul 1 2019;286:159-61. doi: 10.1016\/j.ijcard.2019.01.048.","journal-title":"Int J Cardiol"},{"issue":"8","key":"key20220411085502_B30","first-page":"787","article-title":"Evolocumab in Patients with Cardiovascular Disease","volume":"377","author":"Sabatine","year":"2017","unstructured":". Sabatine MS, Giugliano RP, Pedersen TR. Evolocumab in Patients with Cardiovascular Disease. N Engl J Med. Aug 24 2017;377(8):787-8. doi: 10.1056\/NEJMoa1615664","journal-title":"N Engl J Med"},{"issue":"19","key":"key20220411085502_B31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.116.021314","article-title":"Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population","volume":"134","author":"Kaasenbrood","year":"2016","unstructured":". Kaasenbrood L, Boekholdt SM, van der Graaf Y, Ray KK, Peters RJG, Kastelein JJP, et al. Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population. Circulation. Nov 8 2016;134(19):1419-29. doi: 10.1161\/CIRCULATIONAHA.116.021314.","journal-title":"Circulation"},{"issue":"8","key":"key20220411085502_B32","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma Ceramides","volume":"38","author":"Meeusen","year":"2018","unstructured":". Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB, Jaffe AS. Plasma Ceramides. Arterioscler Thromb Vasc Biol. Aug 2018;38(8):1933-9. doi: 10.1161\/ATVBAHA.118.311199.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"key20220411085502_B33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","unstructured":". Hilvo M, Meikle PJ, Pedersen ER, Tell GS, Dhar I, Bremer H, et al. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. Eur Heart J. Jan 14 2020;41(3):371-80. doi: 10.1093\/eurheartj\/ehz387.","journal-title":"Eur Heart J"},{"issue":"2","key":"key20220411085502_B34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.diabet.2019.07.006","article-title":"Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography","volume":"46","author":"Mantovani","year":"2020","unstructured":". Mantovani A, Bonapace S, Lunardi G, Canali G, Dugo C, Vinco G, et al. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography. Diabetes Metab. Apr 2020;46(2):150-7.","journal-title":"Diabetes Metab"},{"issue":"12","key":"key20220411085502_B35","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/ATVBAHA.118.311927","article-title":"Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy","volume":"38","author":"Mantovani","year":"2018","unstructured":". Mantovani A, Bonapace S, Lunardi G, Canali G, Dugo C, Vinco G, et al. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy. Arterioscler Thromb Vasc Biol. Dec 2018;38(12):2854-61. doi: 10.1016\/j.diabet.2019.07.006.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20220411085502_B36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.metabol.2018.05.006","article-title":"Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy","volume":"85","author":"Mantovani","year":"2018","unstructured":". Mantovani A, Bonapace S, Lunardi G, Salgarello M, Deigo C, Canalli G, et al. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy. Metabolism. Aug 2018;85:305-12. doi: 10.1016\/j.diabet.2019.07.006","journal-title":"Metabolism"},{"issue":"1","key":"key20220411085502_B37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12265-020-09978-3","article-title":"Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence Tomography","volume":"14","author":"Pan","year":"2021","unstructured":". Pan W, Dong H, Sun R, Zhao L, Sun M, Li L, et al. Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence Tomography. J Cardiovasc Transl Res. Mar 24 2021;14(1):140-9. doi: 10.1007\/s12265-020-09978-3.","journal-title":"J Cardiovasc Transl Res"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/ceramidas-plasmaticas-na-estratificacao-de-risco-das-doencas-cardiovasculares\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:08:33Z","timestamp":1747400913000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/ceramidas-plasmaticas-na-estratificacao-de-risco-das-doencas-cardiovasculares\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,7]]}},"alternative-id":["10.36660\/abc.20201165"],"URL":"https:\/\/doi.org\/10.36660\/abc.20201165","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}